The beneficial effects of Lactobacillus brevis FZU0713-fermented Laminaria japonica on lipid metabolism and intestinal microbiota in hyperlipidemic rats fed with a high-fat diet.
- 2021
- Food & Function 12(16)
- Qing Zhang
- Xiaoyun Fan
- Ying-Jia Cao
- T. Zheng
- Wenjian Cheng
- Lijiao Chen
- Xu-Cong Lv
- Li Ni
- P. Rao
- Peng Liang
- PubMed: 34231612
- DOI: 10.1039/d1fo00218j
Abstract
This study aimed to investigate the beneficial effects of the oral administration of Lactobacillus brevis FZU0713-fermented Laminaria japonica (FLJ) on lipid metabolism and intestinal microbiota in hyperlipidemic rats fed with a high-fat diet (HFD). The results demonstrated that the oral administration of FLJ significantly inhibited obesity and improved the serum and hepatic biochemical parameters in HFD-fed rats. Histopathological results also indicated that FLJ intervention could significantly reduce the accumulation of lipid droplets in the liver induced by HFD feeding. Furthermore, FLJ intervention up-regulated the fecal short-chain fatty acid (SCFA) levels (mainly acetate, propionate and isobutyrate) in HFD-fed rats. Intestinal microbiota profiling by 16S rRNA gene sequencing revealed that FLJ intervention increased the relative abundance of Akkermansia, Collinsella, Ruminococcaceae_UCG-013, Defluviitaleaceae_UCG-011, Intestinimonas, Actinomyces and Tyzzerella, but decreased the abundance of Flavonifractor, Collinsella, Sporosarcina and Lacticigenium. Based on Spearman's correlation, the fecal levels of TC, TG, acetic acid and butyric acid were positively correlated with the relative abundance of Akkermansia and Ruminococcaceae_NK4A214, but negatively correlated with the relative amount of Flavonifractor and Collinsella. The metabolic function of intestinal microbiota predicted by PICRUSt analysis of 16S rRNA gene sequences demonstrated that primary and secondary bile acid biosyntheses, fatty acid biosynthesis, taurine and hypotaurine metabolism, arachidonic acid metabolism, glycolysis/gluconeogenesis, etc. were significantly down-regulated after 8 weeks of FLJ intervention. Additionally, FLJ intervention significantly regulated the hepatic mRNA levels (including BSEP, CYP7A1, LDLR, HMGCR, CD36 and SREBP1-C) involved in lipid metabolism and bile acid homeostasis. In conclusion, these findings support the possibility that Laminaria japonica fermented with probiotic Lactobacillus has the potential to reduce the disturbance of lipid metabolism by regulating intestinal microflora and liver gene expression profiles, so it can be employed as a potential functional food to prevent hyperlipidemia.
Research Insights
Supplement | Health Outcome | Effect Type | Effect Size |
---|---|---|---|
Lactobacillus brevis | Improved Abundance of Beneficial Bacteria | Beneficial | Moderate |
Lactobacillus brevis | Increased Fecal Short-Chain Fatty Acid Levels | Beneficial | Moderate |
Lactobacillus brevis | Reduced Liver Lipid Accumulation | Beneficial | Large |
Lactobacillus brevis | Reduced Metabolic Functions of Intestinal Microbiota | Beneficial | Moderate |
Lactobacillus brevis | Reduced Obesity | Beneficial | Large |
Lactobacillus brevis HA-112 | Improved Intestinal Microbial Composition | Beneficial | Large |
Lactobacillus brevis HA-112 | Improved Lipid Metabolism | Beneficial | Large |
Lactobacillus brevis HA-112 | Increased Fecal Short-Chain Fatty Acid Levels | Beneficial | Moderate |
Lactobacillus brevis HA-112 | Reduced Obesity | Beneficial | Large |
Lactobacillus brevis HA-112 | Regulated Liver Gene Expression | Beneficial | Large |
Lactobacillus brevis Lbr-35 | Improved Intestinal Microbiota Composition | Beneficial | Moderate |
Lactobacillus brevis Lbr-35 | Increased Short-Chain Fatty Acid Levels | Beneficial | Moderate |
Lactobacillus brevis Lbr-35 | Reduced Liver Lipid Accumulation | Beneficial | Large |
Lactobacillus brevis Lbr-35 | Reduced Obesity | Beneficial | Large |
Lactobacillus brevis MAK11L82B | Improved Biochemical Parameters | Beneficial | Moderate |
Lactobacillus brevis MAK11L82B | Improved Microbiota Profile | Beneficial | Moderate |
Lactobacillus brevis MAK11L82B | Increased Fecal Short-Chain Fatty Acids | Beneficial | Moderate |
Lactobacillus brevis MAK11L82B | Reduced Hepatic Lipid Accumulation | Beneficial | Moderate |
Lactobacillus brevis MAK11L82B | Reduced Metabolic Functions of Intestinal Microbiota | Beneficial | Moderate |
Lactobacillus brevis MAK11L82B | Reduced Obesity | Beneficial | Large |
Lactobacillus brevis SD-5214 | Altered Gut Microbiota Composition | Beneficial | Moderate |
Lactobacillus brevis SD-5214 | Increased Fecal Short-Chain Fatty Acid Levels | Beneficial | Moderate |
Lactobacillus brevis SD-5214 | Reduced Liver Lipid Accumulation | Beneficial | Large |
Lactobacillus brevis SD-5214 | Reduced Metabolic Functions of Intestinal Microbiota | Beneficial | Moderate |
Lactobacillus brevis SD-5214 | Reduced Obesity | Beneficial | Large |
Lactobacillus brevis UALbr-02 | Altered Gut Microbiota Composition | Beneficial | Moderate |
Lactobacillus brevis UALbr-02 | Increased Fecal Short-Chain Fatty Acid Levels | Beneficial | Moderate |
Lactobacillus brevis UALbr-02 | Reduced Hepatic Lipid Accumulation | Beneficial | Moderate |
Lactobacillus brevis UALbr-02 | Reduced Obesity | Beneficial | Large |
Lactobacillus brevis VPro 18 | Altered Gut Microbiota Composition | Beneficial | Moderate |
Lactobacillus brevis VPro 18 | Increased Fecal Short-Chain Fatty Acid Levels | Beneficial | Moderate |
Lactobacillus brevis VPro 18 | Reduced Liver Lipid Accumulation | Beneficial | Large |
Lactobacillus brevis VPro 18 | Reduced Metabolic Functions of Intestinal Microbiota | Beneficial | Moderate |
Lactobacillus brevis VPro 18 | Reduced Obesity | Beneficial | Large |
Lactobacillus fermentum MAK20L13F | Altered Gut Microbiota Composition | Beneficial | Moderate |
Lactobacillus fermentum MAK20L13F | Improved Lipid Metabolism | Beneficial | Large |
Lactobacillus fermentum MAK20L13F | Increased SCFA Levels | Beneficial | Moderate |
Lactobacillus fermentum MAK20L13F | Reduced Metabolic Function | Beneficial | Moderate |
Lactobacillus fermentum MAK20L13F | Reduced Obesity | Beneficial | Large |
Lactobacillus fermentum MAK20L13F | Regulated Liver Gene Expression | Beneficial | Large |